DIABETES & METABOLIC SYNDROME

STUDIES

A Randomized, Multi-county, Double-blind, Parallel, Placebo-controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy

To learn more about this study, please contact the coordinator here.